# Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI

Study · id `cardio:ct-nct02792712` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02792712](<https://clinicaltrials.gov/study/NCT02792712>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02792712

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT02792712. Randomized; quadruple masking. Start 2016-01 (registry gives no type); primary completion 2018-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking
- Phase: Phase 4
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT02792712, source copy `cardio:ctgov-nct02792712-2016-06-07`, retrieved 2026-10-31)
- Start date: 2016-01 (registry gives no type) (ClinicalTrials.gov record NCT02792712, source copy `cardio:ctgov-nct02792712-2016-06-07`, retrieved 2026-10-31)
- Primary completion: 2018-01 (anticipated) (ClinicalTrials.gov record NCT02792712, source copy `cardio:ctgov-nct02792712-2016-06-07`, retrieved 2026-10-31)
- Completion: 2018-01 (anticipated) (ClinicalTrials.gov record NCT02792712, source copy `cardio:ctgov-nct02792712-2016-06-07`, retrieved 2026-10-31)
- Countries: Taiwan (ClinicalTrials.gov record NCT02792712, source copy `cardio:ctgov-nct02792712-2016-06-07`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02792712-2016-06-07`, retrieved 2026-10-31)

## The registry's words

- Brief title: Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Ticagrelor
- Intervention (Drug): Clopidogrel
- Lead sponsor: Taipei Veterans General Hospital, Taiwan
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry intervention name matches this record: Ticagrelor (`cardio:ticagrelor`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention is a member of this class by a sourced record link: P2Y12 inhibitors (drug class) (`cardio:p2y12-inhibitors`)
- Registry lists this organization as the lead sponsor: Taipei Veterans General Hospital, Taiwan (`cardio:org-taipei-veterans-general-hospital-taiwan`)

## Provenance

Content hash: 7b866364182f10fcb1d0485c1361a1dbb7c72d6c2febe19395b96d1d3d144e1a
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
